Karon BS et al. |
Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. |
2008 |
Clin. Chem. |
pmid:18420732
|
Fiorucci S et al. |
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. |
2002 |
Circulation |
pmid:12473561
|
Rouvier J et al. |
Aspirin resistance. |
2002 |
Circulation |
pmid:12473569
|
Minuz P et al. |
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. |
2002 |
Circulation |
pmid:12451006
|
Hennekens CH et al. |
Terms and conditions: semantic complexity and aspirin resistance. |
2004 |
Circulation |
pmid:15381661
|
Belton O et al. |
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. |
2000 |
Circulation |
pmid:10952950
|
Reilly M et al. |
Modulation of oxidant stress in vivo in chronic cigarette smokers. |
1996 |
Circulation |
pmid:8964113
|
Davì G et al. |
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. |
2003 |
Circulation |
pmid:12810609
|
Patrignani P et al. |
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. |
2000 |
Circulation |
pmid:10920066
|
Davì G et al. |
Oxidative stress and platelet activation in homozygous homocystinuria. |
2001 |
Circulation |
pmid:11535567
|
Maree AO and Fitzgerald DJ |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. |
2007 |
Circulation |
pmid:17452618
|
Cipollone F et al. |
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. |
2002 |
Circulation |
pmid:12135935
|
Capone ML et al. |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. |
2004 |
Circulation |
pmid:15037526
|
Eikelboom JW et al. |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. |
2002 |
Circulation |
pmid:11940542
|
Davì G et al. |
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. |
1999 |
Circulation |
pmid:9892587
|
Cipollone F et al. |
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. |
2003 |
Circulation |
pmid:12515743
|
Eikelboom JW et al. |
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. |
2008 |
Circulation |
pmid:18838564
|
Larsson PT et al. |
Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. |
1994 |
Circulation |
pmid:8181117
|
Cattaneo M |
Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". |
2009 |
Circulation |
pmid:19546394
|
Santilli F et al. |
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. |
2016 |
Circ. J. |
pmid:26632534
|